Abstract:Reactive oxygen species (ROS) play a critical role in the pathogenesis of osteoarthritis. The injection of a single antioxidant drug is characterized by low drug utilization and short residence time in the articular cavity, limiting the therapeutic effect of antioxidant drugs on osteoarthritis. Currently, the drug circu-lation half-life can be extended using delivery vehicles such as liposomes and microspheres, which are widely used to treat diseases. In addition, the composite carriers of liposomes and hydrogel microspheres can combine the advantages of different material forms and show stronger plasticity and flexibility than traditional single carriers, which are expected to become new local drug delivery systems. Chondroitin sulfate, a sulfated glycosaminoglycan commonly found in native cartilage, has good antioxidant properties and degradability and is used to develop an injectable chondroitin sulfate hydrogel by covalent modifi-cation with photo-cross-linkable methacryloyl groups (ChsMA). Herein, ChsMA microgels anchored with liquiritin (LQ)-loaded liposomes (ChsMA@Lipo) were developed to delay the progression of osteoarthri-tis by dual antioxidation. On the one hand, the antioxidant drug LQ wrapped in ChsMA@Lipo microgels exhibits significant sustained-release kinetics due to the double obstruction of the lipid membrane and the hydrogel matrix network. On the other hand, ChsMA can eliminate ROS through degradation into chondroitin sulfate monomers by enzymes in vivo . Therefore, ChsMA@Lipo, as a degradable and dual an-tioxidant drug delivery platform, is a promising option for osteoarthritis treatment.Statement of significanceCompared with the traditional single carrier, the composite carriers of hydrogel microspheres and lipo-some can complement the advantages of different materials, which shows stronger plasticity and flexibil-ity, and is expected to become a new and efficient drug delivery system. ChsMA@Lipo not only attenuates IL-1 beta-induced ECM degradation in chondrocytes but also inhibits the M1 macrophages polarization and the inflammasome activation. The obtained ChsMA@Lipo alleviates the progression of osteoarthritis in vivo , which is promising for osteoarthritis treatment.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

The amelioration of cartilage degeneration by photo-crosslinked GelHA hydrogel and crizotinib encapsulated chitosan microspheres.

Photo-crosslinked HAMA hydrogel with cordycepin encapsulated chitosan microspheres for osteoarthritis treatment.

Chondroitin Sulfate Microspheres Anchored with Drug-Loaded Liposomes Play a Dual Antioxidant Role in the Treatment of Osteoarthritis

Remodeling of the Pro-Inflammatory Microenvironment in Osteoarthritis Via Hydrogel-Based Photothermal Therapy

Using Glucosamine to Improve the Properties of Photocrosslinked Gelatin Scaffolds

Promoting chondrogenesis by targeted delivery to the degenerating cartilage in early treatment of osteoarthritis

Nanoarchitectonics of Injectable Biomimetic Conjugates for Cartilage Protection and Therapy Based on Degenerative Osteoarthritis Progression

Collagen hydrogel-driven pyroptosis suppression and combined microfracture technique delay osteoarthritis progression

In Situ Remodeling of Efferocytosis via Lesion-Localized Microspheres to Reverse Cartilage Senescence

Articular Fibrocartilage-Targeted Therapy by Microtubule Stabilization

Cartilage Targeting Therapy with Reactive Oxygen Species-Responsive Nanocarrier for Osteoarthritis.

A Bionic Thermosensitive Sustainable Delivery System for Reversing the Progression of Osteoarthritis by Remodeling the Joint Homeostasis

Nanozyme-Enhanced Injectable Hydrogel for the Treatment of Osteoarthritis

Inhibition of interleukin-1beta-stimulated dedifferentiation of chondrocytes via controlled release of CrmA from hyaluronic acid-chitosan microspheres

Nanocrystal-chitosan particles for intra-articular delivery of disease-modifying osteoarthritis drugs

Injectable Regenerated Silk Fibroin Micro/Nanosphere with Enhanced Permeability and Stability for Osteoarthritis Therapy

Injectable hydrogel encapsulating siMMP13 with anti-ROS and anti-apoptotic functions for osteoarthritis treatment

Localized Hydrogel Microspheres for Osteoarthritis Treatment: Recruitment and Differentiation of Stem Cells

Chondroprotective Effects of Hyaluronic Acid-Chitosan Nanoparticles Containing Plasmid DNA Encoding Cytokine Response Modifier A in a Rat Knee Osteoarthritis Model

Regulating Chondro‐Bone Metabolism for Treatment of Osteoarthritis via High‐Permeability Micro/Nano Hydrogel Microspheres

Cartilage-targeting and Inflammatory-Responsive Nanocarriers for Effective Osteoarthritis Treatment Via Reactive Oxygen Species Scavenging and Anti-Angiogenesis